Globalization and Health

1 month ago | globalizationandhealth.biomedcentral.com | María Niño |Emanuel Orozco |Eliana Perez |Eliana Pérez |De la Rosa

Participants from sectors such as academia, the media, civil society organizations, and the executive government identified Postobón SA as an outstanding, visible, and active actor in granting incentives. In the interviews, Grupo Nutresa was also distinguished as a predominant actor, along with Bavaria, Coca-Cola, PepsiCo, Nestlé, Alpina, and the National Association of Businessmen of Colombia, Grupo Éxito, which includes its foundation and chain stores with the same name.

1 month ago | globalizationandhealth.biomedcentral.com | Amy Liu |Yasaman Yazdani |Manahel Elias |Krisha Patel |Ammar Saad |Kevin Pottie | +1 more

Our study provides a broad overview of evaluated interventions focusing on improving transitions in care for RIM populations. A variety of often illness-focused programs and population-focused interventions improve safe and effective transition of care and safeguard the continuity of care for vulnerable RIM populations. The most promising studies focused on health care navigation support or education for these populations.

Dec 2, 2024 | globalizationandhealth.biomedcentral.com | Kathleen Rice |Alayne M Adams |Raphael Lencucha |Alua Kulenova

We drew from Bacchi’s “What’s the problem represented to be?” or WPR framework to inform the data collection and analysis approach used in the study. Additionally, we drew from the qualitative descriptive (QD) methodology for its flexibility in adapting a conceptual framework, which ‘allows researchers to place their study findings within a larger context’ to develop knowledge on the topic [16].

Nov 28, 2024 | globalizationandhealth.biomedcentral.com | kings college

The World Health Organization (WHO) commissioned M&C Saatchi World Services, a specialist communication and research unit within M&C Saatchi, to design and implement a multi-country cross-sectional study. Local academic partners were identified in each participating country to provide expert guidance and oversight during implementation of the study, including study design, ethics approval, piloting, adaptation of tools and data collection.

Nov 26, 2024 | globalizationandhealth.biomedcentral.com | Kaixuan Liu |Yuanyuan Cao |Enyu Xu |Yi Wang |Yuhui Xu |Yin Wang | +7 more

Jiangsu Province is in southeastern China and has an area of 102.6 thousand square kilometres (Fig. 1A) [35]. In Jiangsu Province, there are 13 prefecture-level cities, and the permanent population reached 85.15 million by the end of 2022 (Fig. 1B) [36]. Regarding the number of imported malaria cases, Jiangsu Province has consistently ranked among the highest in China, with an annual number ranging from 90 to 405 between 2013 and 2020 [37].